Journal Mobile Options

Vol. 30, Suppl. 1, 2012

Issue release date: October 2012

Innate Immunity in Gastrointestinal Disorders: Basic and Therapeutic Concepts

Falk Symposium 181, Munich, February 2012

See also ISBN 978-3-318-02208-7 for more details
Select / Unselect all
I

Title Page / Table of Contents

Dig Dis 2012;30(suppl 1):I–IV (DOI:10.1159/000342296)
Free Access
Preface
1

Innate Immunity in Gastrointestinal Disorders: Basic and Therapeutic Concepts

Tilg H. · Blumberg R. · Enders S. · Kaser A. · Manns M.
Dig Dis 2012;30(suppl 1):1 (DOI:10.1159/000341113)
Free Access
Autoimmune Liver Disease and PBC: From Animal Models to Innovative Therapies
2

Animal Models for Autoimmune Liver Disease – What Is Relevant for Immune-Mediated Liver Disease

Hardtke-Wolenski M. · Taubert R. · Jaeckel E.
Dig Dis 2012;30(suppl 1):2–10 (DOI:10.1159/000341114)
11

Autoimmune Hepatitis: New Guidelines, New Therapies

Strassburg C.P.
Dig Dis 2012;30(suppl 1):11–19 (DOI:10.1159/000341115)
20

What Is New in Primary Biliary Cirrhosis?

Bogdanos D.P. · Gershwin M.E.
Dig Dis 2012;30(suppl 1):20–31 (DOI:10.1159/000341118)
Innate Immunity: Key Role in Liver Disorders
32

A Lecture on the Genetics of Primary Sclerosing Cholangitis

Karlsen T.H.
Dig Dis 2012;30(suppl 1):32–38 (DOI:10.1159/000341122)
39

Primary Sclerosing Cholangitis: New Approaches to Diagnosis, Surveillance and Treatment

Trauner M. · Halilbasic E. · Baghdasaryan A. · Moustafa T. · Krones E. · Fickert P. · Hofer H. · Penner E.
Dig Dis 2012;30(suppl 1):39–47 (DOI:10.1159/000341123)
48

NK Cells in Hepatitis C: Role in Disease Susceptibility and Therapy

Lunemann S. · Schlaphoff V. · Cornberg M. · Wedemeyer H.
Dig Dis 2012;30(suppl 1):48–54 (DOI:10.1159/000341680)
Fatty Liver Diseases: Innate Immunity as Driving Force for Metabolic Inflammation?
55

Innate Immunity and Alcoholic Liver Disease

Szabo G. · Petrasek J. · Bala S.
Dig Dis 2012;30(suppl 1):55–60 (DOI:10.1159/000341126)
Fatty Liver Diseases: Histopathology and Treatment
61

Nonalcoholic Fatty Liver Disease: What the Pathologist Can Tell the Clinician

Brunt E.M.
Dig Dis 2012;30(suppl 1):61–68 (DOI:10.1159/000341127)
69

Clinical Spectrum and Therapy of Non-Alcoholic Steatohepatitis

Day C.P.
Dig Dis 2012;30(suppl 1):69–73 (DOI:10.1159/000341128)
74

Toll-Like Receptors in Gastrointestinal Diseases

Wagner H.
Dig Dis 2012;30(suppl 1):74–77 (DOI:10.1159/000341129)
The New World of IBD: About Genes, Bacteria and Viruses
78

The Genetics Universe of Crohn’s Disease and Ulcerative Colitis

Parkes M.
Dig Dis 2012;30(suppl 1):78–81 (DOI:10.1159/000341130)
Focus on Innate Immunity in IBD
82

Protective and Aggravating Effects of Nlrp3 Inflammasome Activation in IBD Models: Influence of Genetic and Environmental Factors

Bauer C. · Duewell P. · Lehr H.-A. · Endres S. · Schnurr M.
Dig Dis 2012;30(suppl 1):82–90 (DOI:10.1159/000341681)
91

Animal Models of Inflammatory Bowel Diseases: Illuminating the Pathogenesis of Colitis, Ileitis and Cancer

Neurath M.F.
Dig Dis 2012;30(suppl 1):91–94 (DOI:10.1159/000341131)
Treatment Update of IBD
95

Predicting the Course of IBD: Light at the End of the Tunnel?

Lee J.C.
Dig Dis 2012;30(suppl 1):95–99 (DOI:10.1159/000341132)
The Future of IBD: Genetics Meets Therapeutics
100

New Drug Therapies on the Horizon for IBD

Perrier C. · Rutgeerts P.
Dig Dis 2012;30(suppl 1):100–105 (DOI:10.1159/000341133)
 
106

Falk Symposium Series

Dig Dis 2012;30(suppl 1):106–108 (DOI:10.1159/000342297)
Free Access
109

Author Index Vol. 30, Suppl. 1, 2012

Dig Dis 2012;30(suppl 1):109 (DOI:10.1159/000342299)
Free Access
110

Subject Index Vol. 30, Suppl. 1, 2012

Dig Dis 2012;30(suppl 1):110 (DOI:10.1159/000339698)
Free Access